Document is current
Any future updates will be listed below
-
Authors
Kayaalp, Barış
Kars, Meltem Ece
Itan, Yuval
Başak, Ayşe Nazlı
Casanova, Jean-Laurent
Özçelik, Tayfun
-
Funding
Funding for this research was provided by:
Scientific and Technological Research Council of Türkiye (2211-A)
Suna and Inan Kirac Foundation
Koç University
Howard Hughes Medical Institute
Rockefeller University
St. Giles Foundation
National Institutes of Health (R01AI163029)
National Center for Advancing Translational Sciences (UL1TR001866)
Fisher Center for Alzheimer’s Research Foundation
Meyer Foundation
JPB Foundation
Agence Nationale de la Recherche (ANR-10-IAHU-01)
French Foundation for Medical Research
Square Foundation
Fonds de solidarité pour l’enfance
Fondation du Souffle
William E. Ford, General Atlantic’s Chairman and Chief Executive Officer
Gabriel Caillaux, General Atlantic’s Co-President, Managing Director and Head of Business in EMEA
General Atlantic Foundation
Paris Cité University
Imagine Institute
Leducq Foundation
Turkish Academy of Sciences
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 26 January 2026
First Online: 18 February 2026
Competing interests
: Author T.Ö. is one of the Editorial Board member of npj Genomic Medicine. T.Ö. was not involved in the journal’s review of, or decisions related to, this manuscript. The authors declare no competing financial interests.
